Organic Active Ingredients TRIZ Cases

A glycyrrhizin composition uses hyaluronic acid and a viscosizing agent to enhance topical bioavailability.

Oral L-ornithine phenylacetate formulations resolve the trade-off between ammonia lowering efficacy and patient convenience by replacing intravenous infusion.

5,6-Dihydro-imidazo[1,2-a]pyrazin-8-ylamine derivatives inhibit beta-secretase to block amyloid precursor protein cleavage.

Administering a DPD inhibitor before 5-fluorouracil eliminates enzyme activity to prevent neurotoxicity.

Targeted agents raise plasma membrane tension to inhibit metastasis without affecting normal cell motility.

Using spray-dried sorbitol as a plasticizer reduces melt viscosity and glass transition temperature, enabling stable amorphous solid dispersions.

Simian adenovirus vectors evade pre-existing human anti-Ad5 immunity while maintaining potent immunogenicity for effective vaccines.

New disubstituted diamino-3,4-cyclobutene-1,2-dione compounds treat chemokine-mediated diseases.

Embedding hyaluronic acid liposomes in polyelectrolyte multilayers prevents burst kinetics and systemic dilution.

Inhibiting Chk2 kinase prevents neuronal degeneration and enhances functional recovery by blocking DNA damage-induced apoptosis.

A graphene oxide composite nanoparticle system accumulates at tumor sites and releases chemotherapy drugs via near-infrared light activation.

Enzymatic processing of discarded egg chalaza produces a specific amino acid profile that lowers liver triglycerides and oxidative stress.

Polyamine hydrogel formulations allow higher triptan dosages through increased electrical current without significant skin irritation.

Specific terminal sequences in the peptide resolve electrostatic conflicts, enabling high encapsulation and improved transfection within cells.

Novel compounds inhibit ENT1 transporters to block adenosine uptake.

An oxygen scavenger removes internal oxygen to prevent ropinirole decomposition and crystal precipitation in adhesive patch packages.

Dopamine agonists targeting the D2 receptor family regulate hypothalamic-pituitary-gonadal axis signaling to control hot flashes without hormonal intervention.

PEPTIDE 9 acts as a selective MC5R antagonist to treat depressive disorders with clinical improvement within one to fourteen days.

Vitamin K and collagen hydrolysate composition inhibits transdermal moisture loss to maintain skin barrier function against dryness.

A nutraceutical composition stimulates nitric oxide production to protect human arterial endothelial cells from dysfunction.

Indazole compounds inhibit LRRK2 kinase to treat Parkinson's disease and neurodegeneration.

Single daily trehalose dosing overcomes insufficient brain penetration from continuous water intake to reduce parkinsonian symptoms.

Polycyclic carbamoylpyridone compounds combined with GS-9131 and GS-9148 reduce drug interaction risks while suppressing HIV replication.

A compliant polymeric matrix barrier structure delivers bioactive agents from implantable medical devices.

Compound 1 dosing avoids CYP3A4 metabolism to prevent drug-drug interactions and toxicity in inflammatory disease therapy.

A composition combining nicotinamide and vitamin B6 enhances muscle stem cell amplification and commitment to support skeletal muscle repair.

Segmented synthetic glycopolymers replace complex natural heparin to eliminate contamination risks and ensure predictable bioactivity.

Spermine and spermidine supplementation reduces cortisol while increasing testosterone and DHEAS to resolve estrogen dominance side effects.

Amphiphilic reverse micelles encapsulate nucleic acids to cross cellular membranes, resolving instability in biological fluids.

Low molecular weight alginate stabilizes nanosuspensions at reduced concentrations.

Vacuum deaired poloxamer gels with 1.5 million cP viscosity prevent rapid expulsion and sustain drug release.

Formula II compounds antagonize CGRP receptors to treat migraine without cardiovascular contraindications associated with triptans.

Complexing tart cherry anthocyanins with rosmarinic acid prevents degradation, thereby improving oral bioavailability and efficacy.

A hyaluronic acid mixture combines low and high molecular weight fractions to treat inflammatory bowel disease.

Antisense oligonucleotides reduce toxic PLP1 protein levels to treat Pelizaeus-Merzbacher disease.

Aminopyridine compounds target resistant EGFR mutations while minimizing wild-type inhibition to reduce adverse effects.

A three-step linking process deposits heparin on biological tissue surfaces using a biotin-avidin intermediary layer.

A monoclonal antibody binds to advillin in biological samples to enable precise immunological detection.

Botanical chlorogenic acid composition inhibits acetylcholinesterase and reduces Tau hyperphosphorylation.

Zelpolib selectively inhibits DNA polymerase delta, blocking cancer cell replication while sparing non-dividing cells and reducing side effects.

GalNAc-conjugated oligonucleotides target liver cells to inhibit ANGPTL3 expression, addressing inadequate hypertriglyceridemia treatments.

Formula I and II analogs induce apoptosis in cancer cells by universally inhibiting LSD1, overcoming limited therapeutic benefits of prior inhibitors.

Reversible non-covalent BTK inhibitors overcome C481S mutation resistance while maintaining potency against wild-type targets.

Deuterated domperidone applies kinetic isotope effect to reduce metabolic rate, enabling lower doses that minimize side effects while treating gastroparesis.

A pimecrolimus ointment composition treats moderate to severe blepharitis by reducing eyelid swelling and ocular debris.

Transdermal cannabidiol overcomes oral bioavailability limits, reducing irritability scores in autism patients with high anxiety.

10-substituted morphinan hydantoins modulate peripheral kappa-opioid receptors to provide analgesic effects.

Measuring strain at the elastic and viscous modulus crossover point defines injectable gel flexibility.